Theranostic <sup>64</sup>Cu-DOTHA<sub>2</sub>-PSMA allows low toxicity radioligand therapy in mice prostate cancer model.

Front Oncol · 2023 · PMC9889868 · PMID 36741017

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significancep = 0.09so close (0.05 < p ≤ 0.1)

Likewise, survival was also longer when compared to 177 Lu-PSMA-617, although it did not reach statistical significance ( p = 0.09).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.